IP Library Assignment 023045/0067
Patent Assignment
Reel/Frame 023045/0067

Assignment of Assignor's Interest

Recorded: 2009-08-03 Pages: 35
Assignor
NAUTILUS BIOTECH S.A.
Executed: 2009-06-10
Assignee
HANALL PHARMACEUTICAL CO., LTD.
400-1, SANGSEO-DONG, DAEDEOK-GU,, DAEJEON 306-120, KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF
Covered Property (1)
Modified Erythropoietin Polypeptides and Uses Thereof for Treatment
Patent: 8,252,743 →
Application: 11/998,387 →
Publication: US 2009/0238789
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 14, 2008
From: GUYON, THIERRY; BORRELLY, GILLES; GALLET, XAVIER; DRITTANTI, LILA
To: NAUTILUS BIOTECH, S.A.
Reel/Frame 020656/0647 →
Corrective Assignment to Correct the Assignee's Country Previously Recorded on Reel 023045 Frame 0067. Assignor(S) Hereby Confirms the Assignee's Country Is: the Republic of Korea (South Korea). Nov 5, 2009
From: NAUTILUS BIOTECH S.A.
To: HANALL PHARMACEUTICAL CO., LTD.
Reel/Frame 023474/0635 →
Change of Name May 17, 2010
From: HANALL PHARMACEUTICAL CO., LTD.
To: HANALL BIOPHARMA CO., LTD.
Reel/Frame 024394/0001 →